PATENT CLAIM ANALYSIS

Application Number: 16061115
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "405000"]

Abstract:
Disclosed is a composition including flocoumafen and an amount of a configurational stereoisomer of flocoumafen, named enantiomer E 4 , such that the ratio of this amount to the amount of flocoumafen in the composition is less than 10%, the enantiomer E 4  being present with the exclusion of a racemic mixture, the enantiomer E 4  having, by chromatographic analysis of flocoumafen, a retention time t 4  having a value such that t 1 <t 2 <t 3 <t 4 ; t 1 , t 2  and t 3  representing the retention times of the configurational stereoisomers of flocoumafen different from the enantiomer E 4 , the chromatographic analysis being performed at a temperature of 23.5° C.

Claim (Index 1):
1 - Composition comprising flocoumafen including an amount of a configurational stereoisomer of flocoumafen, named enantiomer E 4 , said enantiomer E 4  being one of the configurational stereoisomers of one of the two diastereoisomers, said diastereoisomer D 1,4 , of flocoumafen, such that the ratio of this amount to the amount of flocoumafen in the composition is less than 10%, said enantiomer E 4  having, by chromatographic analysis of a flocoumafen composition comprising four configurational stereoisomers of flocoumafen, a retention time t 4  having a value such that t 1 <t 2 <t 3 <t 4 ; t 1 , t 2  and t 3  representing the retention times of the configurational stereoisomers of flocoumafen different from said enantiomer E 4 ;\n wherein the amount of said enantiomer E 4  in the composition is different from the amount of a configurational stereoisomer of flocoumafen, named enantiomer E 1 , said enantiomer E 1  being the other configurational stereoisomer of said diastereoisomer D 1,4 , different from said enantiomer E 4  and having, by chromatographic analysis of a flocoumafen composition under the abovementioned conditions, a retention time t 1  having a value such that t 1 <t 2 <t 3 <t 4 ; the chromatographic analysis being performed at a temperature of 23.5\u00b0 C. and under the conditions below:\n on a high-pressure liquid chromatography column of dimensions 150\u00d72 mm, and comprising a chiral stationary phase constituted of particles of tris(4-chloro-3-methylphenyl carbamate) cellulose, said particles having a mean size of 3 \u03bcm and having a mean pore size of 1000 \u212b; \n using, as liquid mobile phase, a mixture formed from acetonitrile (A) and water comprising 0.1% by volume of formic acid (B), with an A/B volume ratio of 92/8 and with a flow rate of the liquid mobile phase in the chromatography column of 0.25 mL/minute; \n by injection into the chromatography column of a volume of 1 \u03bcL of flocoumafen composition at a concentration of 1 \u03bcg of flocoumafen per millilitre of acetonitrile.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 2.18966
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16061084', '15735677', '15318123', '15318195', '13579945']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7447836821412805
- 35 USC 102 Novelty (BERT): 0.550850987779205
- Combined Prediction Score: 0.725390412705073
- Mean Citation Score: 318.567798
- Max Citation Score: 450.95044
- Similarity Product: 287.288744006362

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test